Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson’s disease
暂无分享,去创建一个
Gary W Miller | Claudia M Testa | G. Miller | T. Sherer | T. Yagi | A. Panov | A. Matsuno-Yagi | C. Testa | Todd B Sherer | J Timothy Greenamyre | J. Richardson | Byoung Boo Seo | Takao Yagi | Akemi Matsuno-Yagi | Jason R Richardson | Alexander V Panov | B. Seo | J. Greenamyre | A. Matsuno‐Yagi | G. Miller
[1] A. Murphy,et al. Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)+ oxidation-reduction state. , 2002, The Biochemical journal.
[2] J. Timothy Greenamyre,et al. [3H]Dihydrorotenone Binding to NADH: Ubiquinone Reductase (Complex I) of the Electron Transport Chain: An Autoradiographic Study , 1996, The Journal of Neuroscience.
[3] T. Flotte,et al. A single-subunit NADH-quinone oxidoreductase renders resistance to mammalian nerve cells against complex I inhibition. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.
[4] J. Okun,et al. Three Classes of Inhibitors Share a Common Binding Domain in Mitochondrial Complex I (NADH:Ubiquinone Oxidoreductase)* , 1999, The Journal of Biological Chemistry.
[5] Gary W Miller,et al. Paraquat neurotoxicity is distinct from that of MPTP and rotenone. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[6] C. C. Johnson,et al. The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living , 1998, Neurology.
[7] M. Zigmond,et al. Loss of dopaminergic neurons in parkinsonism: possible role of reactive dopamine metabolites. , 1997, Journal of neural transmission. Supplementum.
[8] M. Thun,et al. Pesticide exposure and risk for Parkinson's disease , 2006, Annals of neurology.
[9] P. Lümmen,et al. Complex I inhibitors as insecticides and acaricides. , 1998, Biochimica et biophysica acta.
[10] F. Sharp,et al. MK-801 reduces uptake and stimulates efflux of excitatory amino acids via membrane depolarization. , 1996, The American journal of physiology.
[11] Todd B. Sherer,et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.
[12] J. Casida,et al. The insecticide target in the PSST subunit of complex I. , 2001, Pest management science.
[13] T. Flotte,et al. Use of the NADH-Quinone Oxidoreductase (NDI1) Gene ofSaccharomyces cerevisiae as a Possible Cure for Complex I Defects in Human Cells* , 2000, The Journal of Biological Chemistry.
[14] C. Hoppel,et al. Riboflavin and rat hepatic cell structure and function. Mitochondrial oxidative metabolism in deficiency states. , 1979, The Journal of biological chemistry.
[15] J. Parks,et al. Abnormalities of the electron transport chain in idiopathic parkinson's disease , 1989, Annals of neurology.
[16] J. Langston,et al. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.
[17] Y. Kagawa,et al. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. , 1989, Biochemical and biophysical research communications.
[18] J. Paul Robinson,et al. Mitochondrial Complex I Inhibitor Rotenone Induces Apoptosis through Enhancing Mitochondrial Reactive Oxygen Species Production* , 2003, The Journal of Biological Chemistry.
[19] E. Bézard,et al. Neuroprotective agents for clinical trials in Parkinson’s disease: A systematic assessment , 2004, Neurology.
[20] H. Forman,et al. Glutathione Depletion in PC12 Results in Selective Inhibition of Mitochondrial Complex I Activity , 2000, The Journal of Biological Chemistry.
[21] S. Khuder,et al. A meta-analysis of Parkinson's disease and exposure to pesticides. , 2000, Neurotoxicology.
[22] C. Moraes,et al. Titrating the Effects of Mitochondrial Complex I Impairment in the Cell Physiology* , 1999, The Journal of Biological Chemistry.
[23] M. Beal. Oxidatively modified proteins in aging and disease. , 2002, Free radical biology & medicine.
[24] M. Beal,et al. Mitochondrial dysfunction in neurodegenerative diseases. , 1998, Biochimica et biophysica acta.
[25] L. Tretter,et al. The Production of Reactive Oxygen Species in Intact Isolated Nerve Terminals Is Independent of the Mitochondrial Membrane Potential , 2003, Neurochemical Research.
[26] R. Albin,et al. Neuroprotective agents for clinical trials in Parkinson’s disease , 2003, Neurology.
[27] Todd B. Sherer,et al. Mechanism of Toxicity in Rotenone Models of Parkinson's Disease , 2003, The Journal of Neuroscience.
[28] A. Matsuno-Yagi,et al. Lack of Complex I Activity in Human Cells Carrying a Mutation in MtDNA-encoded ND4 Subunit Is Corrected by theSaccharomyces cerevisiae NADH-Quinone Oxidoreductase (NDI1) Gene* , 2001, The Journal of Biological Chemistry.
[29] D. Muller,et al. A simple method for organotypic cultures of nervous tissue , 1991, Journal of Neuroscience Methods.
[30] W. Tatton,et al. Etiology and pathogenesis of Parkinson's disease. , 1999, Annual review of neuroscience.
[31] Gary W Miller,et al. Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[32] T. Sherer,et al. Environment, Mitochondria, and Parkinson's Disease , 2002, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[33] A. H. V. Schapira,et al. MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE , 1989, The Lancet.
[34] S. Przedborski,et al. Oxidative Stress in Parkinson's Disease , 2008, Annals of the New York Academy of Sciences.
[35] Todd B. Sherer,et al. Subcutaneous Rotenone Exposure Causes Highly Selective Dopaminergic Degeneration and α-Synuclein Aggregation , 2003, Experimental Neurology.
[36] S. Khuder,et al. Environmental risk factors and Parkinson's disease: a metaanalysis. , 2001, Environmental research.
[37] M. Degli Esposti. Inhibitors of NADH-ubiquinone reductase: an overview. , 1998, Biochimica et biophysica acta.
[38] T. Sherer,et al. Complex I and Parkinson's Disease , 2001, IUBMB life.
[39] E. Love,et al. Parkinson's disease and exposure to agricultural work and pesticide chemicals , 1992, Neurology.
[40] M. Beal. Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease , 2003, Annals of the New York Academy of Sciences.
[41] A single-subunit NADH-quinone oxidoreductase renders resistance to mammalian nerve cells against complex I inhibition. , 2003 .
[42] A. Panov,et al. Quantitative evaluation of the effects of mitochondrial permeability transition pore modifiers on accumulation of calcium phosphate: comparison of rat liver and brain mitochondria. , 2004, Archives of biochemistry and biophysics.
[43] W. Nicklas,et al. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. , 1985, Life sciences.
[44] Todd B. Sherer,et al. An In Vitro Model of Parkinson's Disease: Linking Mitochondrial Impairment to Altered α-Synuclein Metabolism and Oxidative Damage , 2002, The Journal of Neuroscience.
[45] A J McLean,et al. Pesticides and Parkinson's disease. , 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[46] A. Panov,et al. Substrate specific effects of calcium on metabolism of rat heart mitochondria. , 1996, The American journal of physiology.
[47] D. Higgins,et al. Quantitative Autoradiography of Dihydrorotenone Binding to Complex I of the Electron Transport Chain , 1992, Journal of neurochemistry.
[48] C. Fall,et al. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. , 1997, Biochimica et biophysica acta.
[49] Claudia M Testa,et al. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures. , 2005, Brain research. Molecular brain research.